MoneyWorks4Me

Piramal Pharma - Quaterly Results

08 Feb 2023 Evaluate
The quarter ended December 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 8132.90 millions.The Net Loss for the quarter ended December 2022 is Rs. -24.20 millions as compared to Net Profit of Rs. 1117.60 millions of corresponding quarter ended December 2021Operating profit for the quarter ended December 2022 decreased to 811.50 millions as compared to 1945.70 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202212 202112 % Var
Sales 8132.90 7961.30 2.16 8132.90 7961.30 2.16 8132.90 7961.30 2.16
Other Income 538.80 568.70 -5.26 538.80 568.70 -5.26 538.80 568.70 -5.26
PBIDT 811.50 1945.70 -58.29 811.50 1945.70 -58.29 811.50 1945.70 -58.29
Interest 332.20 152.80 117.41 332.20 152.80 117.41 332.20 152.80 117.41
PBDT 479.30 1792.90 -73.27 479.30 1792.90 -73.27 479.30 1792.90 -73.27
Depreciation 471.90 406.60 16.06 471.90 406.60 16.06 471.90 406.60 16.06
PBT 7.40 1386.30 -99.47 7.40 1386.30 -99.47 7.40 1386.30 -99.47
TAX 31.60 268.70 -88.24 31.60 268.70 -88.24 31.60 268.70 -88.24
Deferred Tax -18.30 -3.60 408.33 -18.30 -3.60 408.33 -18.30 -3.60 408.33
PAT -24.20 1117.60 -102.17 -24.20 1117.60 -102.17 -24.20 1117.60 -102.17
Equity 11933.20 11859.10 0.62 11933.20 11859.10 0.62 11933.20 11859.10 0.62
PBIDTM(%) 9.98 24.44 -59.17 9.98 24.44 -59.17 9.98 24.44 -59.17
Peers
Company Name CMP
Sun Pharma. Inds. 1846.00
Dr. Reddys Labs. 1229.40
Cipla 1390.60
Lupin 2071.00
Zydus Lifesciences 1216.25
View more..